Figure 4 Also, inflammation, multifocal demyelination, loss of oligodendrocytes, breakdown of the blood-brain barrier (BBB), neural and axonal injury, and oxidative stress are the causes of MS (Van der Walt et al., 2010
For those with known retinopathy, more frequent ophthalmology review may be indicatedtypically every 36 months depending on severity
NICE and MHRA Guidance on Weight Management With Renal Impairment In the UK, weight management pharmacotherapy is governed primarily by NICE guidance , with drug safety oversight provided by the Medicines and Healthcare products Regulatory Agency (MHRA)
How will you react when you see your goal weight on the scale
They had a body mass index (BMI) of at least 30 on the date of treatment initiation or during the latest available primary care visit, or a BMI of at least 27 with one or more weight-related comorbidities such as hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease
The whoosh effect, where weight remains stable for weeks then drops several pounds suddenly, is particularly common during Retatrutide treatment
